Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2451-2458

  Boyle, Julia ^a   Eriksson, Malin E V ^a   Gribble, Laura ^a   Gouni, Ravi ^b   Johnsen, Sigurd ^a   Coppini, David V ^c   Kerr, David ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DULOXETINE; PLACEBO; PREGABALIN;

ADULT; AGED; ANALGESIC ACTIVITY; AROUSAL; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PERIPHERAL NEUROPATHIC PAIN; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EVENING DOSAGE; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PARALLEL DESIGN; PHYSICAL ACTIVITY; POLYSOMNOGRAPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSORIMOTOR FUNCTION; SIDE EFFECT; SLEEP QUALITY; SLEEP TIME; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; WAKEFULNESS;

AGED; AMITRIPTYLINE; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; SLEEP; THIOPHENES; TREATMENT OUTCOME;

EID: 84869843911     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0656     Document Type: Article

References (40)

1. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61:160-173; quiz 175-176
2. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998;91:733-737 (Pubitemid 28508618)
3. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-128 (Pubitemid 30009719)
4. O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009;27:95-112
5. Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am 2004;88:947-999, xi (Pubitemid 39090347)
6. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-251 (Pubitemid 350051570)
7. Moulin DE, Clark AJ, Gilron I, et al.; Canadian Pain Society. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12:13-21 (Pubitemid 46744774)
8. Jose VM, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007;24:377-383 (Pubitemid 46452398)
9. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an openlabel pilot study. J Pain Symptom Manage 2000;20:280-285
10. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118 (Pubitemid 40828506)
11. Smith T, Nicholson RA. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc Health Risk Manag 2007;3:833-844
12. Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010;149:360-364
13. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexibleand fixed-dose regimens. Pain 2005;115:254-263 (Pubitemid 40725282)
14. Asplund R. Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res 2004;56:517-525 (Pubitemid 38686691)
15. Resnick HE, Redline S, Shahar E, et al.; Sleep Heart Health Study. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003;26:702-709 (Pubitemid 36929331)
16. Lopes LA, Lins CdeM, Adeodato VG, et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 2005;28:2633-2636 (Pubitemid 43951151)
17. Bendtson I, Gade J, Theilgaard A, Binder C. Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia. Diabetologia 1992;35:898-903
18. Pallayova M, Donicova V, Donic V. Association between nocturnal hyperglycaemia and severe sleep-disordered breathing in type 2 diabetic patients: a study based on continuous glucose monitoring. Diabetologia 2006;49(Suppl. 1):152
19. Moldofsky H. Sleep and pain. Sleep Med Rev 2001;5:385-396
20. Tölle T, Freynhagen R, Versavel M, Trostmann U, Young JP Jr. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, doubleblind study. Eur J Pain 2008;12:203-213 (Pubitemid 350180540)
21. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28:187-193 (Pubitemid 40362644)
22. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147-157 (Pubitemid 32367946)
23. Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999;53:46-50 (Pubitemid 29012351)
24. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138
25. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-197 (Pubitemid 18029372)
26. Zisapel N, Laudon M. Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review. Hum Psychopharmacol 2003;18:1-20 (Pubitemid 36192954)
27. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 1980;10:189-209 (Pubitemid 10049156)
28. Gillberg M, Kecklund G, Akerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep 1994;17:236-241 (Pubitemid 24174455)
29. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System of Sleep Stages in Human Subjects. Washington, DC, U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1968
30. Wechsler D. Wechsler Adult Intelligence Scale - Revised. New York, The Psychological Corporation, 1981
31. Baddeley AWM. AWorking Memory. OUP, Oxford. Oxford, OUP, 1986
32. Sternberg S. High-speed scanning in human memory. Science 1966;153:652-654
33. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256
34. Fairweather DB, Kerr JS, Hilton S, Hindmarch I. A placebo controlled doubleblind evaluation of the pharmacodynamics of fengabine vs. amitriptyline following single and multiple doses in elderly volunteers. Br J Clin Pharmacol 1993;35:278-283 (Pubitemid 23074053)
35. Hindmarch I, Trick L, Ridout F. A doubleblind, placebo- and positive-internalcontrolled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl) 2005;183:133-143 (Pubitemid 41609265)
36. Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Guzmán D, Guàrdia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 2009;43:855-863
37. Chalon S, Pereira A, Lainey E, et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl) 2005;177:357-365
38. Gursky JT, Krahn LE. The effects of antidepressants on sleep: a review. Harv Rev Psychiatry 2000;8:298-306 (Pubitemid 32046388)
39. Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008;43:70-75
40. Saletu-Zyhlarz GM, Mandl M, Gruber G, Divos H, Jenull B, Saletu B. Placebocontrolled polysomnographic and psychometric studies on the acute effects of pregabalin in insomnia related to neurotic and stress-related disorders and sleep-related movement disorders. J Sleep Res 2006;15(Suppl. 1):40